Kent Reifschneider is an Endocrinology/Metabolic physician affiliated with Children's Hospital of The King's Daughters. OpenAlex indexes 14 publications with 693 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 Childrens Ln
Norfolk, VA 235071910
Telephone
757-668-7237Registry record last updated 19 Feb 2019.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ascendis Pharma IncProgram year2023112 payments$53,154openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20236 payments
- Novo Nordisk IncProgram year20235 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
100%l-Thyroxine100%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury
Growth Hormone & IGF Research
2022 - Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial
Hormone Research in Paediatrics
2022 - Using change in predicted adult height during GnRH agonist treatment for individualized treatment decisions in girls with central precocious puberty
Journal of Pediatric Endocrinology and Metabolism
2022 - Using Partnerships to Create a Medical Specialty Camp for Youth with Diabetes
Journal of Park and Recreation Administration
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Crystal Proud, MD
Children's Hospital of The King's Daughters
Irene Restaino, MD
Children's Hospital of The King's Daughters
Georg Dahl, MD
Children's Hospital of The King's Daughters
John Birknes, MD
Children's Hospital of The King's Daughters
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”